In vivo benzo[a]pyrene diol epoxide-induced alkali-labile sites are not apurinic sites

Mutat Res. 1991 Feb;262(2):79-84. doi: 10.1016/0165-7992(91)90111-g.

Abstract

We have used endonuclease IV from Escherichia coli as a probe for apurinic sites in the DNA of HeLa cells following treatment with an activated diol epoxide derivative of benzo[a]pyrene. DNA strand breaks and alkali-labile sites were observed that were repaired following exposure to the carcinogenic alkylating agent. The alkali-labile sites were not substrates for the apurinic site-specific endonuclease IV. We conclude that the alkali-labile sites formed in vivo by benzo[a]pyrene derivatives are not apurinic sites and probably arise as a consequence of rearrangement of the abundant N2-guanine adducts. This finding questions the involvement of apurinic sites in the mutagenic activity of benzo[a]pyrene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / pharmacology*
  • Alkalies
  • DNA Damage*
  • DNA-(Apurinic or Apyrimidinic Site) Lyase
  • Deoxyribonuclease IV (Phage T4-Induced)
  • Endodeoxyribonucleases
  • Escherichia coli Proteins*
  • HeLa Cells
  • Humans

Substances

  • Alkalies
  • Escherichia coli Proteins
  • 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
  • Endodeoxyribonucleases
  • Deoxyribonuclease IV (Phage T4-Induced)
  • endonuclease IV, E coli
  • DNA-(Apurinic or Apyrimidinic Site) Lyase